We are live on ! Find out more
ELAN icon

Elanco Animal Health

440 hedge funds and large institutions have $14.1B invested in Elanco Animal Health in 2020 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 165 increasing their positions, 100 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

273% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 30

65% more repeat investments, than reductions

Existing positions increased: 165 | Existing positions reduced: 100

38% more funds holding in top 10

Funds holding in top 10: 811 (+3)

22% more capital invested

Capital invested by funds: $11.5B → $14.1B (+$2.57B)

22% more funds holding

Funds holding: 360440 (+80)

9.5% more ownership

Funds ownership: 87.65%97.15% (+9.5%)

36% less call options, than puts

Call options by funds: $46.7M | Put options by funds: $73.1M

Holders
440
Holders Change
+80
Holders Change %
+22.22%
% of All Funds
7.79%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.19%
New
112
Increased
165
Reduced
100
Closed
30
Calls
$46.7M
Puts
$73.1M
Net Calls
-$26.4M
Net Calls Change
+$22.4M
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
276
AlphaCrest Capital Management
New York
$549K +$256K +8,400 +88%
Voloridge Investment Management
277
Voloridge Investment Management
Florida
$535K -$3.59M -117,545 -87%
CF
278
Centaurus Financial
California
$526K -$29K -950 -5%
OC
279
Oppenheimer & Co
New York
$525K -$207K -6,775 -28%
Rafferty Asset Management
280
Rafferty Asset Management
New York
$518K +$88.2K +2,891 +21%
GI
281
GAMCO Investors
Connecticut
$517K +$514K +16,852 New
DTL
282
Dynamic Technology Lab
Singapore
$508K +$506K +16,574 New
EGM
283
Engineers Gate Manager
New York
$505K +$503K +16,477 New
NERM
284
New England Research & Management
Illinois
$494K -$137K -4,500 -22%
CIS
285
Connors Investor Services
Pennsylvania
$481K -$644K -21,100 -57%
OFG
286
Oxford Financial Group
Indiana
$479K +$199K +6,538 +72%
HF
287
HRT Financial
New York
$477K -$1.17M -38,412 -71%
BCM
288
Brasada Capital Management
Texas
$475K +$473K +15,500 New
DC
289
Davenport & Co
Virginia
$465K -$18.3K -600 -4%
IRF
290
IBM Retirement Fund
New York
$462K +$35.1K +1,150 +8%
LFM
291
Lumina Fund Management
New York
$460K
SACTSONJ
292
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
$460K
Mackenzie Financial
293
Mackenzie Financial
Ontario, Canada
$446K +$74.3K +2,436 +20%
First Manhattan
294
First Manhattan
New York
$444K -$16K -525 -3%
TC
295
TwinBeech Capital
New York
$439K +$437K +14,323 New
CIBC Asset Management
296
CIBC Asset Management
Ontario, Canada
$435K -$4.12K -135 -0.9%
PCM
297
Parsons Capital Management
Rhode Island
$415K -$47K -1,542 -10%
LA
298
LVW Advisors
New York
$399K +$151K +4,938 +61%
First Trust Advisors
299
First Trust Advisors
Illinois
$388K +$148K +4,835 +62%
CG
300
Cutler Group
California
$380K +$343K +11,239 +952%

ELAN Hedge Fund Activity: Q4 2020 in Review

440 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q4 2020, worth a combined $14.1B — up 22% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new ELAN positions and 30 closed out — a net gain of 82 holders — while 165 added to existing stakes and 100 trimmed.

The largest buyer was Sachem Head Capital Management, adding an estimated $743M. The largest seller was UBS Group, cutting an estimated $368M.

  • 440 institutional investors held Elanco Animal Health (ELAN) as of Q4 2020, up from 360 in Q3 2020.
  • Funds reported $14.1B of Elanco Animal Health stock for Q4 2020, up 22% quarter-over-quarter.
  • 112 funds opened new Elanco Animal Health positions in Q4 2020 and 30 closed out, a net change of +82 holders.
  • The largest Elanco Animal Health buyer in Q4 2020 was Sachem Head Capital Management, an estimated $743M added.
  • The largest Elanco Animal Health seller in Q4 2020 was UBS Group, an estimated $368M sold.

Based on aggregated 13F filings for Q4 2020.